October 8, 2026 at 4:00 AM UTCUpdated on October 8, 2026 at 6:58 AM UTCTakeaways by Bloomberg AIIsomorphic Labs, an Alphabet Inc. company using artificial intelligence to discover drugs, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the matter. The round could value Isomorphic Labs, which spun out of Google DeepMind, at as much as $50 billion, one of the people said. The financing hasn’t closed and details could change, the people...